Webinar: Optimize CGT manufacturing to enable timely and affordable patient access

Create efficient and purposeful manufacturing practices to keep costs down and increase patient satisfaction

It’s well known that the biggest barrier to CGT commercialization is growing cost. Structural complexities, combined with a lack of standardization across the industry drive up expense and threaten to price out the patients that need them most.

Hear from industry experts Martha Rook, Chief Technical Operations at Insitro; Craig Malzah, VP, Technical Operations at REGENXBIO; Alessandro Linciano, Site Manufacturing Science & Technology Head, Cell & Gene Therapy at Novartis and Thermo Fisher Scientific as they share their expert knowledge and insights.

You’ll learn how to:
. Collaborate and share examples of GMP to establish industry-wide standardization and enable CGT usage as a frontline therapy
. Understand the benefits of digitalization in the supply chain, such as in therapy development and in the custody chain, to enhance your own process
. Partner with solution providers to identify pain points in the manufacturing process and strategize to remedy them

comments powered by Disqus